Advanced search
Publication Cover
Infection and Drug Resistance Volume 16, 2023 - Issue
Submit an article Journal homepage
115
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Chlamydia psittaci Pneumonia-Induced Pulmonary Thrombosis: A Case Report

Changquan Fang1 Department of Pulmonary and Critical Care Medicine, Huizhou Central People’s Hospital, Huizhou, Guangdong Province, Peoples’ Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-4971-1407View further author information
ORCID Icon &
Limin Xu2 Department of Geriatrics, Huizhou First People’s Hospital, Huizhou, Guangdong Province, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 7063-7069 | Received 08 Sep 2023, Accepted 26 Oct 2023, Published online: 06 Nov 2023

References

  • Fang C, Xu L, Tan J, et al. Case Report: Chlamydia psittaci pneumonia complicated by Guillain-Barré syndrome detected using metagenomic next-generation sequencing. Front Cell Infect Microbiol. 2023;12:1070760. doi:10.3389/fcimb.2022.1070760
  • Knittler MR, Sachse K. Chlamydia psittaci: update on an underestimated zoonotic agent. Pathog Dis. 2015;73(1):1–15. doi:10.1093/femspd/ftu007
  • Balsamo G, Maxted AM, Midla JW, et al. Compendium of measures to control Chlamydia psittaci infection among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017. J Avian Med Surg. 2017;31(3):262–282. doi:10.1647/217-265
  • Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol. 2023;20(4):248–262. doi:10.1038/s41569-022-00787-6
  • Zhang Z, Zhou H, Cao H, et al. Human-to-human transmission of Chlamydia psittaci in China, 2020: an epidemiological and aetiological investigation. Lancet Microbe. 2022;3(7):e512–e520. doi:10.1016/S2666-5247(22)00064-7
  • Hogerwerf L, Gier DE, Baan B, et al. Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis. Epidemiol Infect. 2017;145(15):3096–3105. doi:10.1017/S0950268817002060
  • He Y, Wang S, Deng J, et al. Chlamydia psittaci pneumonia complicated with lower extremity atherosclerotic occlusive disease. Infect Drug Resist. 2023;16:2141–2145. doi:10.2147/IDR.S393256
  • Li H, Hao B, Wang Y, et al. Metagenomic next-generation sequencing for the diagnosis of Chlamydia psittaci pneumonia. Clin Respir J. 2022;16(7):513–521. doi:10.1111/crj.13519
  • Yang M, Yang DH, Yang H, et al. Clinical characteristics of Chlamydia psittaci pneumonia infection in Central South China. Infect Dis Ther. 2022;11(4):1631–1647. doi:10.1007/s40121-022-00662-4
  • Yang F, Li J, Qi B, et al. Clinical symptoms and outcomes of severe pneumonia caused by Chlamydia psittaci in Southwest China. Front Cell Infect Microbiol. 2022;11:727594. doi:10.3389/fcimb.2021.727594
  • Liu S, Cui Z, Carr MJ, et al. Chlamydia psittaci should be a notifiable infectious disease everywhere. Lancet Microbe. 2023;4(2):e62–e63. doi:10.1016/S2666-5247(22)00306-8
  • Chen X, Cao K, Wei Y, et al. Metagenomic next-generation sequencing in the diagnosis of severe pneumonias caused by Chlamydia psittaci. Infection. 2020;48(4):535–542. doi:10.1007/s15010-020-01429-0
  • Cui Z, Meng L. Psittacosis pneumonia: diagnosis, treatment and interhuman transmission. Int J Gen Med. 2023;16:1–6. doi:10.2147/IJGM.S396074
  • Li N, Cai Q, Miao Q, et al. High-throughput metagenomics for identification of pathogens in the clinical settings. Small Methods. 2021;5(1):2000792. doi:10.1002/smtd.202000792
  • Song S, Xu Y. A retrospective study of the clinical characteristics of 9 children with pulmonary embolism associated with Mycoplasma pneumoniae pneumonia. BMC Pediatr. 2023;23(1):370. doi:10.1186/s12887-023-04188-7
  • Rókusz L. Case of Legionella pneumonia complicated with pulmonary thromboembolism. Acta Microbiol Immunol Hung. 2010;57(4):401–406. doi:10.1556/AMicr.57.2010.4.6
  • Zhang Z, Wang P, Ma C, et al. Host inflammatory response is the major factor in the progression of Chlamydia psittaci pneumonia. Front Immunol. 2022;13:929213. doi:10.3389/fimmu.2022.929213
  • Poor HD. Pulmonary thrombosis and thromboembolism in COVID-19. Chest. 2021;160(4):1471–1480. doi:10.1016/j.chest.2021.06.016
  • Zhang Y, Zhou Q, Zou Y, et al. Risk factors for pulmonary embolism in patients preliminarily diagnosed with community-acquired pneumonia: a prospective cohort study. J Thromb Thrombolysis. 2016;41(4):619–627. doi:10.1007/s11239-015-1275-6
  • Jolobe OMP. Similarities between community-acquired pneumonia and pulmonary embolism. Am J Med. 2019;132:e863. doi:10.1016/j.amjmed.2019.03.002
  • Kearon C, de Wit K, Parpia S, et al. Diagnosis of pulmonary embolism with d-Dimer adjusted to clinical probability. N Engl J Med. 2019;381(22):2125–2134. doi:10.1056/NEJMoa1909159
  • Crawford F, Andras A, Welch K, et al. D-dimer test for excluding the diagnosis of pulmonary embolism. Cochrane Database Syst Rev. 2016;2016(8):CD010864. doi:10.1002/14651858.CD010864.pub2
  • Freund Y, Cohen-Aubart F, Bloom B. Acute pulmonary embolism: a review. JAMA. 2022;328(13):1336–1345. doi:10.1001/jama.2022.16815
  • Tritschler T, Kraaijpoel N, Le Gal G, et al. Venous thromboembolism: advances in diagnosis and treatment. JAMA. 2018;320(15):1583–1594. doi:10.1001/jama.2018.14346

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.